343
Views
7
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Efficacy and toxicity of decitabine versus CHG regimen (low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor) in patients with higher risk myelodysplastic syndrome: a retrospective study

, , , , , , , , , , & show all
Pages 1367-1374 | Received 19 May 2015, Accepted 15 Sep 2015, Published online: 16 Nov 2015
Supplemental material

GLAL-2015-0506-File005.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File006.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File007.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File008.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File009.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File010.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File011.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File012.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File013.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File014.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File015.pdf

Download PDF (1.2 MB)

GLAL-2015-0506-File016.pdf

Download PDF (1.2 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.